CustomVis to raise £2.4m for sales ramp-up of ophthalmic laser
This article was originally published in Clinica
Executive Summary
Australian eye laser equipment company CustomVis is expecting to raise £2.4m ($4.7m) in a bid to grow its sales and marketing activities. The firm, listed on the UK AIM stock exchange, has issued around 73.8 million new shares, priced at 3.25p each. It said the proceeds will go towards recruiting more sales staff, expanding its manufacturing capacity, and conducting preliminary work for clinical trials in the US.